Lantheus Biosciences

• NCT05641688

  Phase 3, Recruiting, 200 people, 8 Dec 2022

• NCT05337774

  Phase 1, Terminated, 18 people, 20 Apr 2022

• NCT04715750

  Collaborator, Phase 1, Completed, 10 people, 20 Jan 2021

• Impact of FBB PET Amyloid Imaging in Change of Diagnosis in Patients With AD

  Phase 4, Completed, 218 people, 12 Feb 2016

• NCT02531360

  Collaborator, Early phase 1, Completed, 7 people, 24 Aug 2015

• NCT01138111

  Phase 1, Completed, 45 people, 7 Jun 2010

• NCT01020838

  Phase 3, Completed, 218 people, 26 Nov 2009

• NCT00928304

  Phase 2, Completed, 109 people, 25 Jun 2009

• NCT00750282

  Phase 2, Completed, 422 people, 10 Sept 2008

Sources: clinicaltrials.gov